Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,561 | -32,213 | -32,482 | -8,095 | N/A |
| Depreciation Amortization | 510 | 131 | 159 | 84 | N/A |
| Other Working Capital | -340 | -146 | 6,704 | -1,005 | N/A |
| Other Operating Activity | -2,477 | 8,053 | -1,054 | 1,442 | 0 |
| Operating Cash Flow | $-42,868 | $-24,175 | $-26,673 | $-7,573 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 47,367 | 6,228 | -63,641 | N/A | N/A |
| PPE Investments | -53 | -17 | -12 | -18 | N/A |
| Purchase Sale Intangibles | N/A | -340 | -268 | -155 | N/A |
| Other Investing Activity | 0 | 838 | -103 | -38 | 0 |
| Investing Cash Flow | $47,314 | $7,049 | $-63,756 | $-56 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 90,257 | 60,650 | N/A |
| Other Financing Activity | 0 | 0 | -8,746 | -4,807 | 0 |
| Financing Cash Flow | $N/A | $N/A | $81,511 | $55,843 | $N/A |
| Exchange Rate Effect | 739 | 1,563 | -1,834 | 931 | N/A |
| Beginning Cash Position | 25,243 | 41,970 | 51,275 | 4,777 | N/A |
| End Cash Position | 30,428 | 26,408 | 40,524 | 53,921 | N/A |
| Net Cash Flow | $5,185 | $-15,562 | $-10,751 | $49,144 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,868 | -24,175 | -26,673 | -7,573 | N/A |
| Capital Expenditure | -53 | -17 | -12 | -18 | N/A |
| Free Cash Flow | -42,921 | -24,192 | -26,685 | -7,592 | 0 |